Dirk Van den Berge
Overview
Explore the profile of Dirk Van den Berge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
1154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamel R, Van den Berge D
J Med Case Rep
. 2024 Jul;
18(1):330.
PMID: 39030575
Background: Subependymal giant cell astrocytoma is a benign brain tumor that occurs in patients with tuberous sclerosis complex. Surgical removal is the traditional treatment, and expert opinion is strongly against...
2.
Tijtgat J, Calliauw E, Dirven I, Vounckx M, Kamel R, Vanbinst A, et al.
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37174026
Focal radiation necrosis of the brain (fRNB) is a late adverse event that can occur following the treatment of benign or malignant brain lesions with stereotactic radiation therapy (SRT) or...
3.
Wang H, Bouzakoura S, de Mey S, Jiang H, Law K, Dufait I, et al.
Oncotarget
. 2017 Apr;
8(22):35728-35742.
PMID: 28415723
Auranofin (AF) is an anti-arthritic drug considered for combined chemotherapy due to its ability to impair the redox homeostasis in tumor cells. In this study, we asked whether AF may...
4.
Leonard W, Dufait I, Schwarze J, Law K, Engels B, Jiang H, et al.
Radiother Oncol
. 2016 Feb;
119(2):291-9.
PMID: 26874542
Background And Purpose: High arginase-1 (Arg) expression by myeloid-derived suppressor cells (MDSC) is known to inhibit antitumor T-cell responses through depletion of l-arginine. We have previously shown that nitric oxide...
5.
Soffietti R, Kocher M, Abacioglu U, Villa S, Fauchon F, Baumert B, et al.
J Clin Oncol
. 2012 Dec;
31(1):65-72.
PMID: 23213105
Purpose: This phase III trial compared adjuvant whole-brain radiotherapy (WBRT) with observation after either surgery or radiosurgery of a limited number of brain metastases in patients with stable solid tumors....
6.
Jiang H, Verovski V, Leonard W, Law K, Vermeersch M, Storme G, et al.
Int J Radiat Oncol Biol Phys
. 2012 Sep;
85(3):820-7.
PMID: 22975619
Purpose: To determine whether host hepatocytes may reverse hypoxic radioresistance through nitric oxide (NO)-induced oxygen sparing, in a model relevant to colorectal cancer (CRC) liver metastases. Methods And Materials: Hepatocytes...
7.
Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert B, et al.
J Clin Oncol
. 2010 Nov;
29(2):134-41.
PMID: 21041710
Purpose: This European Organisation for Research and Treatment of Cancer phase III trial assesses whether adjuvant whole-brain radiotherapy (WBRT) increases the duration of functional independence after surgery or radiosurgery of...
8.
Bretz A, Van den Berge D, Storme G
Neurosurgery
. 2003 Nov;
53(6):1429-31.
PMID: 14633311
Objective And Importance: Epidermoid cysts are benign lesions that account for 0.7% of all intraspinal tumors. Standard treatment is complete resection. The recurrence rate after surgery cannot be estimated from...
9.
Soete G, Verellen D, Michielsen D, Vinh-Hung V, Van De Steene J, Van den Berge D, et al.
Int J Radiat Oncol Biol Phys
. 2002 Oct;
54(3):948-52.
PMID: 12377349
Purpose: To evaluate accuracy and time requirements of a stereoscopic X-ray-based positioning system in patients receiving conformal radiotherapy to the prostate. Methods And Materials: Setup errors of the isocenter with...
10.
Soete G, Van De Steene J, Verellen D, Vinh-Hung V, Van den Berge D, Michielsen D, et al.
Int J Radiat Oncol Biol Phys
. 2002 Feb;
52(3):694-8.
PMID: 11849791
Purpose: To evaluate an infrared (IR) marker-based positioning system in patients receiving conformal radiotherapy for prostate cancer. Methods And Materials: During 553 treatments, the ability of the IR system to...